Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 46: 1022-a-1023-a, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watts, B.
Right arrow Articles by Chesher, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Watts, B.
Right arrow Articles by Chesher, D.
Related Collections
Right arrow Evidence Based Laboratory Medicine and Test Utilization
(Clinical Chemistry. 2000;46:1022-1023.)
© 2000 American Association for Clinical Chemistry, Inc.


Letters

Measurement of Total Protein Is Not a Useful Inclusion in Liver Function Test Profiles

Bhoji Watts1, Leslie Burnett2,3,a and Doug Chesher2

1 Institute of Clinical Pathology, and Medical Research, Westmead Hospital, Westmead NSW 2145, Australia

2 Pacific Laboratory Medicine Services, (PaLMS), Royal North Shore Hospital, St. Leonards NSW 2065, Australia

3 Department of Pathology, University of Sydney, Sydney NSW 2006, Australia
a Address correspondence to this author at: Pacific Laboratory Medicine Services (PaLMS), Royal North Shore Hospital, St. Leonards NSW 2065, Australia. Fax 61-2-9926-6395; e-mail Lburnett@med.usyd.edu.au.


To the Editor:

Biochemical and hematological pathology investigations often are requested using groupings or profiles of tests. In Australia, "liver function test" (LFT) is recognized by legislation (1) and consists of six or more tests, including alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, albumin, (total) bilirubin, {gamma}-glutamyl transpeptidase, lactate dehydrogenase, and (total) protein. Historically, although total protein has been included as a part of LFT, the total protein measurement is not specific for abnormal liver function or liver damage. We have examined whether the routine inclusion of total protein as a component of LFT leads to new diagnoses or alters patients’ clinical management.

At the time of this study, our laboratory primarily serviced a large, tertiary referral university teaching hospital. Total protein was measured using the Biuret method (2) on a Hitachi 747 analyzer (Boehringer-Mannheim/Roche Diagnostics). Using a computer, we examined 15 000 consecutive unselected requests, including ambulatory and hospitalized patients, received by our laboratory over a 3-month period in which the requesting clinician had specified (among other things) that a "LFT" biochemical profile was to be performed. From this sample population of 15 . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
K. Hayden and C. van Heyningen
Measurement of Total Protein Is a Useful Inclusion in Liver Function Test Profiles
Clin. Chem., April 1, 2001; 47(4): 793 - 794.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.